ID   RET_RAT                 Reviewed;        1115 AA.
AC   G3V9H8; Q9EPA1; Q9EPC3;
DT   22-JAN-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 1.
DT   02-OCT-2024, entry version 90.
DE   RecName: Full=Proto-oncogene tyrosine-protein kinase receptor Ret;
DE            EC=2.7.10.1;
DE   Contains:
DE     RecName: Full=Soluble RET kinase fragment;
DE   Contains:
DE     RecName: Full=Extracellular cell-membrane anchored RET cadherin 120 kDa fragment;
DE   Flags: Precursor;
GN   Name=Ret;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=11328649; DOI=10.3109/10425170009033991;
RA   Matera I., De Miguel-Rodriguez M., Fernandez-Santos J.M., Santamaria G.,
RA   Puliti A., Ravazzolo R., Romeo G., Galera-Davidson H., Ceccherini I.;
RT   "cDNA sequence and genomic structure of the rat RET proto-oncogene.";
RL   DNA Seq. 11:405-417(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   INTERACTION WITH CBLC AND CD2AP, AND TISSUE SPECIFICITY.
RX   PubMed=18753381; DOI=10.1523/jneurosci.2738-08.2008;
RA   Tsui C.C., Pierchala B.A.;
RT   "CD2AP and Cbl-3/Cbl-c constitute a critical checkpoint in the regulation
RT   of ret signal transduction.";
RL   J. Neurosci. 28:8789-8800(2008).
RN   [5]
RP   FUNCTION.
RX   PubMed=23333276; DOI=10.1016/j.celrep.2012.12.011;
RA   Glerup S., Lume M., Olsen D., Nyengaard J.R., Vaegter C.B., Gustafsen C.,
RA   Christensen E.I., Kjolby M., Hay-Schmidt A., Bender D., Madsen P.,
RA   Saarma M., Nykjaer A., Petersen C.M.;
RT   "SorLA controls neurotrophic activity by sorting of GDNF and its receptors
RT   GFRalpha1 and RET.";
RL   Cell Rep. 3:186-199(2013).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=28846099; DOI=10.1038/nm.4394;
RA   Yang L., Chang C.C., Sun Z., Madsen D., Zhu H., Padkjaer S.B., Wu X.,
RA   Huang T., Hultman K., Paulsen S.J., Wang J., Bugge A., Frantzen J.B.,
RA   Noergaard P., Jeppesen J.F., Yang Z., Secher A., Chen H., Li X., John L.M.,
RA   Shan B., He Z., Gao X., Su J., Hansen K.T., Yang W., Joergensen S.B.;
RT   "GFRAL is the receptor for GDF15 and is required for the anti-obesity
RT   effects of the ligand.";
RL   Nat. Med. 23:1158-1166(2017).
CC   -!- FUNCTION: Receptor tyrosine-protein kinase involved in numerous
CC       cellular mechanisms including cell proliferation, neuronal navigation,
CC       cell migration, and cell differentiation in response to glia cell line-
CC       derived growth family factors (GDNF, NRTN, ARTN, PSPN and GDF15) (By
CC       similarity). In contrast to most receptor tyrosine kinases, RET
CC       requires not only its cognate ligands but also coreceptors, for
CC       activation (By similarity). GDNF ligands (GDNF, NRTN, ARTN, PSPN and
CC       GDF15) first bind their corresponding GDNFR coreceptors (GFRA1, GFRA2,
CC       GFRA3, GFRA4 and GFRAL, respectively), triggering RET
CC       autophosphorylation and activation, leading to activation of downstream
CC       signaling pathways, including the MAPK- and AKT-signaling pathways
CC       (PubMed:23333276). Acts as a dependence receptor via the GDNF-GFRA1
CC       signaling: in the presence of the ligand GDNF in somatotrophs within
CC       pituitary, promotes survival and down regulates growth hormone (GH)
CC       production, but triggers apoptosis in absence of GDNF (By similarity).
CC       Required for the molecular mechanisms orchestration during intestine
CC       organogenesis via the ARTN-GFRA3 signaling: involved in the development
CC       of enteric nervous system and renal organogenesis during embryonic
CC       life, and promotes the formation of Peyer's patch-like structures, a
CC       major component of the gut-associated lymphoid tissue (By similarity).
CC       Mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced
CC       cell-signaling in the brainstem which triggers an aversive response,
CC       characterized by nausea, vomiting, and/or loss of appetite in response
CC       to various stresses (By similarity). Modulates cell adhesion via its
CC       cleavage by caspase in sympathetic neurons and mediates cell migration
CC       in an integrin (e.g. ITGB1 and ITGB3)-dependent manner (By similarity).
CC       Also active in the absence of ligand, triggering apoptosis through a
CC       mechanism that requires receptor intracellular caspase cleavage (By
CC       similarity). Triggers the differentiation of rapidly adapting (RA)
CC       mechanoreceptors (By similarity). Involved in the development of the
CC       neural crest (By similarity). Regulates nociceptor survival and size
CC       (By similarity). Phosphorylates PTK2/FAK1 (By similarity).
CC       {ECO:0000250|UniProtKB:P07949, ECO:0000250|UniProtKB:P35546,
CC       ECO:0000269|PubMed:23333276}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:P07949};
CC   -!- SUBUNIT: Phosphorylated form interacts with the PBT domain of DOK2,
CC       DOK4 and DOK5 (By similarity). The phosphorylated form interacts with
CC       PLCG1 and GRB7 (By similarity). Interacts (not phosphorylated) with
CC       PTK2/FAK1 (via FERM domain) (By similarity). Extracellular cell-
CC       membrane anchored RET cadherin fragments form complex in neurons with
CC       reduced trophic status, preferentially at the contact sites between
CC       somas (By similarity). Interacts with AIP in the pituitary gland; this
CC       interaction prevents the formation of the AIP-survivin complex (By
CC       similarity). Interacts (inactive) with CBLC and CD2AP; dissociates upon
CC       activation by GDNF which increases CBLC:CD2AP interaction
CC       (PubMed:18753381). {ECO:0000250|UniProtKB:P07949,
CC       ECO:0000250|UniProtKB:P35546, ECO:0000269|PubMed:18753381}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P07949};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P07949}.
CC       Endosome membrane {ECO:0000250|UniProtKB:P07949}; Single-pass type I
CC       membrane protein {ECO:0000250|UniProtKB:P07949}. Note=Predominantly
CC       located on the plasma membrane. In the presence of SORL1 and GFRA1,
CC       directed to endosomes. {ECO:0000250|UniProtKB:P07949}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Ret51;
CC         IsoId=G3V9H8-1; Sequence=Displayed;
CC       Name=2; Synonyms=Ret9;
CC         IsoId=G3V9H8-2; Sequence=VSP_053545, VSP_053546, VSP_053547;
CC   -!- TISSUE SPECIFICITY: Expressed in neurons and kidney glomeruli podocytes
CC       (at protein level) (PubMed:18753381). Detected at least in colon,
CC       duodenum, adipose tissue, heart, jejenum, lung, muscle, spleen, stomac,
CC       testis and thymus (PubMed:28846099). {ECO:0000269|PubMed:18753381,
CC       ECO:0000269|PubMed:28846099}.
CC   -!- PTM: Autophosphorylated on C-terminal tyrosine residues upon ligand
CC       stimulation. {ECO:0000250|UniProtKB:P07949}.
CC   -!- PTM: Proteolytically cleaved by caspase-3. The soluble RET kinase
CC       fragment is able to induce cell death. The extracellular cell-membrane
CC       anchored RET cadherin fragment accelerates cell adhesion in sympathetic
CC       neurons (By similarity). {ECO:0000250|UniProtKB:P07949}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ299016; CAC10568.1; -; mRNA.
DR   EMBL; AJ299017; CAC10569.1; -; mRNA.
DR   EMBL; AJ298999; CAC10584.1; -; Genomic_DNA.
DR   EMBL; AJ299000; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299001; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299002; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299003; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299004; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299005; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299006; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299007; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299008; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299009; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299010; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299011; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299012; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299013; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299014; CAC10584.1; JOINED; Genomic_DNA.
DR   EMBL; AJ298999; CAC10583.1; -; Genomic_DNA.
DR   EMBL; AJ299000; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299001; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299002; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299003; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299004; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299005; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299006; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299007; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299008; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299009; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299010; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299011; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299012; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299013; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299014; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AJ299015; CAC10583.1; JOINED; Genomic_DNA.
DR   EMBL; AABR06033186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473964; EDM02082.1; -; Genomic_DNA.
DR   EMBL; CH473964; EDM02083.1; -; Genomic_DNA.
DR   RefSeq; NP_036775.2; NM_012643.2. [G3V9H8-1]
DR   RefSeq; XP_017447959.1; XM_017592470.1.
DR   AlphaFoldDB; G3V9H8; -.
DR   SMR; G3V9H8; -.
DR   BioGRID; 246844; 4.
DR   STRING; 10116.ENSRNOP00000047793; -.
DR   BindingDB; G3V9H8; -.
DR   ChEMBL; CHEMBL4295641; -.
DR   GlyCosmos; G3V9H8; 9 sites, No reported glycans.
DR   GlyGen; G3V9H8; 9 sites.
DR   iPTMnet; G3V9H8; -.
DR   PhosphoSitePlus; G3V9H8; -.
DR   PaxDb; 10116-ENSRNOP00000047793; -.
DR   DNASU; 24716; -.
DR   Ensembl; ENSRNOT00000047685.5; ENSRNOP00000047793.3; ENSRNOG00000014751.8. [G3V9H8-1]
DR   GeneID; 24716; -.
DR   KEGG; rno:24716; -.
DR   AGR; RGD:3556; -.
DR   CTD; 5979; -.
DR   RGD; 3556; Ret.
DR   eggNOG; KOG0200; Eukaryota.
DR   GeneTree; ENSGT00940000158499; -.
DR   HOGENOM; CLU_009530_0_0_1; -.
DR   InParanoid; G3V9H8; -.
DR   OMA; CDVVENQ; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; G3V9H8; -.
DR   TreeFam; TF317640; -.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-8853659; RET signaling.
DR   PRO; PR:G3V9H8; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Proteomes; UP000234681; Chromosome 4.
DR   Bgee; ENSRNOG00000014751; Expressed in cerebellum and 16 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005769; C:early endosome; IDA:RGD.
DR   GO; GO:0010008; C:endosome membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098797; C:plasma membrane protein complex; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0007169; P:cell surface receptor protein tyrosine kinase signaling pathway; ISO:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; ISO:RGD.
DR   GO; GO:0001838; P:embryonic epithelial tube formation; ISO:RGD.
DR   GO; GO:0048484; P:enteric nervous system development; ISO:RGD.
DR   GO; GO:0160144; P:GDF15-GFRAL signaling pathway; ISO:RGD.
DR   GO; GO:0035860; P:glial cell-derived neurotrophic factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   GO; GO:0060384; P:innervation; IMP:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0033619; P:membrane protein proteolysis; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0001755; P:neural crest cell migration; ISO:RGD.
DR   GO; GO:0007158; P:neuron cell-cell adhesion; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0042551; P:neuron maturation; ISO:RGD.
DR   GO; GO:0061146; P:Peyer's patch morphogenesis; ISO:RGD.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0045793; P:positive regulation of cell size; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0072300; P:positive regulation of metanephric glomerulus development; ISO:RGD.
DR   GO; GO:0014042; P:positive regulation of neuron maturation; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISO:RGD.
DR   GO; GO:0033141; P:positive regulation of peptidyl-serine phosphorylation of STAT protein; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISO:RGD.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0048265; P:response to pain; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEP:RGD.
DR   GO; GO:0035799; P:ureter maturation; ISO:RGD.
DR   GO; GO:0001657; P:ureteric bud development; ISO:RGD.
DR   CDD; cd11304; Cadherin_repeat; 1.
DR   CDD; cd05045; PTKc_RET; 1.
DR   Gene3D; 2.60.40.60; Cadherins; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR041163; Ret_CLD1.
DR   InterPro; IPR040667; Ret_CLD3.
DR   InterPro; IPR041317; RET_CLD4.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016249; Tyr_kinase_Ret_rcpt.
DR   PANTHER; PTHR24416:SF485; PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF00028; Cadherin; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF17756; RET_CLD1; 1.
DR   Pfam; PF17812; RET_CLD3; 1.
DR   Pfam; PF17813; RET_CLD4; 1.
DR   Pfam; PF22540; RET_CRD; 1.
DR   PIRSF; PIRSF000631; TyrPK_receptor_Ret; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49313; Cadherin-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50268; CADHERIN_2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Cell adhesion; Cell membrane;
KW   Disulfide bond; Endosome; Glycoprotein; Kinase; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome; Signal;
KW   Transferase; Transmembrane; Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..1115
FT                   /note="Proto-oncogene tyrosine-protein kinase receptor Ret"
FT                   /id="PRO_0000424874"
FT   CHAIN           29..708
FT                   /note="Extracellular cell-membrane anchored RET cadherin
FT                   120 kDa fragment"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT                   /id="PRO_0000424875"
FT   CHAIN           709..1018
FT                   /note="Soluble RET kinase fragment"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT                   /id="PRO_0000424876"
FT   TOPO_DOM        24..637
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        638..658
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        659..1115
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          168..273
FT                   /note="Cadherin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          725..1017
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          29..153
FT                   /note="Cadherin-like region 1 (CLD1)"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   REGION          266..380
FT                   /note="Cadherin-like region 3 (CLD3)"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   REGION          406..507
FT                   /note="Cadherin-like region 4 (CLD4)"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   ACT_SITE        875
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         178
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         179
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         230
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         232
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         232
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         265
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         266
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         267
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         268
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         268
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         269
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         301
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         303
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         303
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         379
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         565
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         566
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         568
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         570
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         575
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         585
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   BINDING         731..739
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         759
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            708..709
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   SITE            1018..1019
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         688
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         697
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         807
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         810
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         827
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         901
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         906
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         982
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         1016
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         1030
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         1063
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         1091
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   MOD_RES         1097
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        151
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        156
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        199
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        378
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        395
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        449
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        469
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        555
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        689
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   DISULFID        137..142
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   DISULFID        157..197
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   DISULFID        166..243
FT                   /evidence="ECO:0000250|UniProtKB:P07949"
FT   VAR_SEQ         922..928
FT                   /note="ESLFDHI -> NSLSDHF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11328649"
FT                   /id="VSP_053545"
FT   VAR_SEQ         1065..1073
FT                   /note="MSDPNWPGE -> RISHAFTRF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11328649"
FT                   /id="VSP_053546"
FT   VAR_SEQ         1074..1115
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11328649"
FT                   /id="VSP_053547"
FT   CONFLICT        30
FT                   /note="Y -> C (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        90
FT                   /note="S -> A (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        264
FT                   /note="Y -> YD (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        356
FT                   /note="K -> R (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        389
FT                   /note="V -> F (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        552
FT                   /note="I -> T (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        628
FT                   /note="G -> A (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        749
FT                   /note="G -> D (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        917
FT                   /note="K -> N (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        975
FT                   /note="D -> N (in Ref. 1; CAC10568/CAC10583)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1115 AA;  124237 MW;  BF6EE55077F10F35 CRC64;
     MAKARSGAAG LGLKLFLLLP LLGEAPLGLY FSRDAYWERL YVDQPAGTPL LYVHALRDAP
     GEVPSFRLGQ YLYGVYRTRL HENDWIHIDS GTGLLYLNQS LDHSSWEQLS IRNGGFPLLT
     VFLQVFLGST AQREGECHWP GCARVYFSFI NDTFPNCSSF KARDLCTPET GVSFRIRENR
     PPGTFYQFRM LPVQFLCPNI SVKYKLLEGD GLPFRCDPDC LEVSTRWALD RELQEKYVLE
     AECAVAGPGA NKEKVAVSFP VTVYDEDDSP PTFSGGVGTA SAVVEFKRKE GTVVATLQVF
     DADVVPASGE LVRRYTSTLL SGDSWAQQTF RVEHTPNETL VQSNNNSVRA TMHNYKLVLN
     RSLSISESRV LQLVVLVNDS DFQGPGSGVL FLHFNVSVLP VTLNLPMAYS FPVNRRARRY
     AQIGKVCVEN CQEFSGVSIQ YKLQPSSTNC SALGVVTSTE DTSGTLYVND TEALRRPECT
     ELQYTVVATD RQTRRQTQAS LVVTVEGTYI AEEVGCPKSC AVNKRRPECE ECGGLGSPTG
     RCEWRQGDGK GITRNFSTCS PSTRTCPDGH CDALESRDIN ICPQDCLRGP IVGGHERGER
     QGIKAGYGIC NCFPDEKKCF CEPEDSQGPL CDELCRTVIT AAVLFSFIIS VLLSTFCIHR
     YHKHAHKPPI ASAEMTFCRP AQGFPISYSS SGTRRPSLDS MENQVSVDSF KIPEDPKWEF
     PRKNLVLGKT LGEGEFGKVV KATAFRLKGR AGYTTVAVKM LKENASQSEL RDLLSEFNLL
     KQVNHPHVIK LYGACSQDGP LLLIVEYAKY GSLRGFLRDS RKIGPAYVSS GGSRNSSSLD
     HPDERVLTMG DLISFAWQIS RGMQYLAEMK LVHRDLAARN ILVAEGRKMK ISDFGLSRDV
     YEEDSYVKKS KGRIPVKWMA IESLFDHIYT TQSDVWSFGV LLWEIVTLGG NPYPGIPPER
     LFNLLKTGHR MERPDNCSEE MYRLMLQCWK QEPDKRPVFA DISKDLEKMM VKSRDYLDLA
     ASTPSDSLLY DDGLSEEETP LVDCNSAPLP RSLPSTWIEN KLYGMSDPNW PGESPVPLTR
     ADGTSTGFPR YANDSVYANW MVSPSAAKLM DTFDS
//
